The global regenerative medicine market size was valued at USD 30.43 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 16.79% from 2024 to 2030. Recent advancements in biological therapies have resulted in a gradual shift in preference toward personalized medicinal strategies over the conventional treatment approach. This has created opportunities for companies that are involved in the development of biological therapeutics. Furthermore, the rise in the incidence of degenerative disorders has led to an increase in focus on research to discover novel regenerative therapies.

The COVID-19 outbreak has considerably impacted various markets, including the regenerative medicine and T-cell therapy manufacturing market. The SARS-CoV-2 coronavirus crisis has significantly affected the delivery of CAR T-cell therapies. This impact is not just limited to patient care. It has extended beyond patient care to administration, logistics, and limited healthcare resources. Several universities have slowed down clinical trial enrollment and other research activities. However, the market continues to expand as market players such as Novartis provide access to therapies like Athersys, Inc.’s MultiStem, which is a highly relevant COVID-19 therapy.

Gather more insights about the market drivers, restrains and growth of the Global regenerative medicine market

Regenerative Medicine Market Segments Highlights:

• The therapeutics segment held the largest market share of 76.24% in 2023, owing to the growing geriatric population coupled with higher incidence rates of age-related as well as degenerative disorders.
• The banks segment is expected to witness the fastest CAGR of 17.34% from 2024 to 2030. Banks are usually research-focused and are established with an intention to accelerate research by reducing the efforts, time, and cost for researchers in the collection, storage, and curation of human tissues or cells.
• The oncology segment held the largest market share in 2023 and is expected to witness the fastest CAGR of 17.62% from 2024 to 2030. The growing prevalence of cancer is expected to positively influence the global market throughout the forecast period.
• The cardiovascular segment is anticipated to witness significant growth during the forecast period. Advancements in cell-based therapies and regenerative medicines have accelerated the growth of the segment.
• North America held the largest market share in the global market in 2023. The high growth is attributed to the availability of government and private funding for development, the presence of advanced tech frameworks to support the rapid detection of chronic diseases and high healthcare spending in the region.
• Europe is expected to experience the fastest CAGR of 18.79% from 2024 to 2030. This growth rate is attributed to the rapid adoption of cell-based approaches in healthcare, the rising geriatric population in the region, and the emergence of key players.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Tissue Engineering Market: The global tissue engineering market size was estimated at USD 19.36 billion in 2024 and is projected to witness a CAGR of 14.3% from 2025 to 2030.
• Stem Cells Market: The global stem cells market size was estimated at USD 15.10 billion in 2024 and is expected to grow at a CAGR of 11.41% from 2025 to 2030.

Regenerative Medicine Market Segmentation

Grand View Research has segmented the global Regenerative Medicine market on the basis product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

• Therapeutics
  • Primary cell-based therapeutics
    • Dermatology
    • Musculoskeletal
    • Surgical
    • Dental
    • Others
  • Stem Cell & Progenitor Cell-based therapeutics
    • Autologous
    • Allogenic
    • Others
  • Cell-based Immunotherapies
  • Gene Therapies
• Tools
• Banks
• Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2018 - 2030)

• Dermatology
• Musculoskeletal
• Immunology & Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Regenerative Medicine Market Intelligence Study, published by Grand View Research.